[MYGN] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -29.31%
YoY- -166.83%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 191,900 183,500 181,200 177,800 156,400 179,300 164,900 10.62%
PBT -61,200 -116,100 -52,600 -52,100 -44,200 -17,900 -26,400 75.06%
Tax 100 -1,900 2,100 -9,800 -9,100 -3,800 -5,900 -
NP -61,300 -116,100 -54,700 -42,300 -35,100 -14,100 -20,500 107.41%
Tax Rate - - - - - - - -
Total Cost 253,200 299,600 235,900 220,100 191,500 193,400 185,400 23.07%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -31.94 -63.27 -30.19 -23.79 -22.44 -7.86 -12.43 87.49%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.75 -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 102.50%
EPS Diluted -0.75 -1.42 -0.67 -0.52 -0.43 -0.18 -0.26 102.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.